onabotulinumtoxinA X (OnabotA X)
/ AbbVie
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 26, 2023
Characteristics and Treatment Response to OnabotulinumtoxinA in Patients With Anterocollis and Retrocollis From the Cervical Dystonia Patient Registry for the Observation of OnabotulinumtoxinA Efficacy
(PHYSIATRY 2023)
- "CD PROBE data indicate that real-world treatment with onabotA relieves CD symptoms in patients with anterocollis and retrocollis, as evaluated by patient and physician assessments."
1 to 1
Of
1
Go to page
1